We used the Shapiro test for normality to identify genes with skewed or otherwise distorted distributions; the analysis revealed no differences between the two groups.
A systematic review also reported that four of five studies included in the analysis revealed no differences in strength improvements produced by exercise training with and without whole body vibration (Nordlund and Thorstensson 2007).
All in all, 67%% of the clinical outcome comparisons included in this analysis revealed no difference between original and generic drug therapy effectiveness with generic therapy, and therefore, supported our first hypothesis.
Results of the CLBP patients were additionally analyzed on differences between the two subgroups but this analysis revealed no differences with respect to RT between the two subgroups.
For males, this analysis revealed no differences in the slopes of the lines (F = 0.20, P = 0.81) (Figure 5A), but did reveal differences in intercept (F = 17.5, P<0.0001).
The data analysis revealed no difference in the association of copy number and expression changes between regions of gain or loss.
With regard to lumiracoxib, in the TARGET Therapeutic Arthritis Researchh and Gastrointestinal Event Trial) study [ 40] the primary analysis revealed no difference when naproxen and ibuprofen were considered as a single group.
The Kaplan Meier analysis revealed no difference in OS between those groups of patients (P=0.56).
The interim analysis revealed no difference in overall survival (OS; primary end point) between treatment arms; however, progression-free survival (PFS) and objective response rate were significantly superior with BEV PAC.
A t-test on the average of all the electrodes considered in the anterior positive shift analysis revealed no difference between groups (t(28) = .39, P = .70).70
The G-V curve analysis revealed no difference in the half-maximal activation voltage of I K (Fig. S1B) between the control (31.24 ± 3.86 mV, n = 17) and flotillin-1 overexpressing neurons (32.56 ± 1.48 mV, n = 23).
